Skip to main content

Table 3 The post-operative data from the patients both groups

From: Perioperative infusion of low- dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-A double-blind randomized study

Characteristics

Group A

Group B

p

Mortality

Surgical mortality

0(%)

3 (12%)

0.235

Hemodynamic profil

Cardiac Index (L/min/m 2 )

3.2 ± 0.7

3.0 ± 0.8

0,352

Heart rate (/min)

78 ± 11

83 ± 9

0,085

PVR

198 ± 40

214 ± 29

0,112

Mean PAP (mm Hg)

21 ± 4

19 ± 4

0,084

Mean AP (mm Hg)

84 ± 11

78 ± 7

0,026

SVR (dyn.cm/m 2 )

1210 ± 102

1103 ± 123

0.002

CVP (mm Hg)

8.5 ± 2.5

7 ± 1.8

0.019

EF

38.0 ± 3.9

35.5 ± 4.1

0.032

Vasodilatory shock (pts)

1 (8%)

6 (20%)

0.042

Inotropic needs

Needed norepinephrine (pts)

6

18

0.002

Needed additional epinephrine (pts)

5

17

0.001

Mean catecholamine infusion-time (Hours)

10 ± 4

18 ± 6

0,000

Mean norepinephrine-dose μg/Kg/min

0.16 ± 0.04

0.44 ± 0.07

0,000

Blood-loss and urine output

Mean blood loss (ml)

650 ± 125

975 ± 100

0,000

Mean urine volume (ml)

5603 ± 1450

3910 ± 1102

0.000

Transfusion needs

Mean erythrocytes' units transfused

3.1 ± 1.7

4.2 ± 1.8

0.031

Mean plasma's units transfused

6.1 ± 2.3

5.8 ± 3.1

0.699

Mean platelets' units transfused

4.3 ± 1.8

5.7 ± 2.1

0,015